Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care-Reference-Cited by-同舟云学术

Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care

Published:2021-12 Issue: Volume:94 Page:39-44
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Taramasso Lucia^ORCID,Magnasco Laura^ORCID,Portunato Federica^ORCID,Briano Federica,Vena Antonio,Giacobbe Daniele R.,Dentone Chiara^ORCID,Robba Chiara,Ball Lorenzo,Loconte Maurizio,Patroniti Nicolò^ORCID,Frisoni Paolo,D'Angelo Raffaele,Dettori Silvia,Mikulska Malgorzata,Pelosi Paolo,Bassetti Matteo

Publisher

Elsevier BV

Subject

Internal Medicine

Reference42 articles.

1. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality;Zhang;Int J Antimicrob Agents,2020

2. Clinical characteristics, management and in-hospital mortality of patients with COVID-19;Vena,2020

3. Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection: a question needing an answer;Lombardi;J Hospital Infect [Internet],2020

4. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia;Mikulska;PLoS ONE [Internet],2020

5. Risk of infections in rheumatoid arthritis patients treated with tocilizumab;Lang;Rheumatology [Oxford],2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Interventions in Coronavirus Disease 2019 Pleural and Pulmonary Complications: A Case Series of the Tertiary Thoracic Surgery Center Experience;Surgical Infections;2023-12-01

2. The association between tocilizumab and the secondary bloodstream infection maybe nonsignificant in hospitalized patients with SARS-CoV-2 infection: A cohort study;Journal of Microbiology, Immunology and Infection;2023-11

3. Immune regulators for the treatment of COVID-19: A critical appraisal after two years;European Journal of Internal Medicine;2023-10

4. Plant Extracts and SARS-CoV-2: Research and Applications;Life;2023-01-31

5. Infectious complications of the respiratory tract and lungs in patients with post-COVID syndrome;Infusion & Chemotherapy;2022-12-28